Novartis Q4 net profit rises to $2.0 billionJanuary 29, 2014 @ 12:02 am
GENEVA (AP) - Swiss drug maker Novartis AG reported a 2 percent rise in fourth-quarter net profit Wednesday, helped by delays in generic competition to its blockbuster drugs.
The Basel, Switzerland-based company said it had a net profit of $2.029 billion attributable to shareholders in the final three months of 2013, up from a restated $1.985 billion in the same period the previous year.
Chief Executive Joseph Jimenez said Novartis delivered a strong performance in 2013, growing both net sales and core operating income in constant currencies while absorbing patent expirations.
"We maintained good momentum in innovation," he said in a financial statement. "Our growth products continued to expand, rejuvenating our portfolio and reinforcing our growth prospects."
Full-year net profit fell 1 percent to $9.175 billion attributable to shareholders, down from $9.27 billion in 2012. Net sales were up 4 percent despite the generic competition and core operating income grew 3 percent, both measured in constant currencies, Novartis said.
The financial statement was delivered before trading opened on the Zurich exchange, where shares closed at 71.3 Swiss francs ($79.3) Tuesday. Shares are up 14 percent from a year ago.
The company confirmed its outlook for 2014 sales growth is in the low to mid-single digits, assuming that the launch of a generic contender to the Novartis blockbuster blood-pressure drug Diovan is delayed until the second quarter.
(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Councilwoman Kshama Sawant is upset that Boeing pays less for electricity than residents
What We Learned
Danny O'Neil says the gap between Seattle & the rest of the NFL isn't as big as we thought
Why investors are shifting away from cancer and heart disease research
Please login below with your Facebook, Twitter, Google+ or Disqus account. Existing MyNorthwest account holders will need to create a new Disqus account or use one of the social logins provided below. Thank you.